Related Experiment Video
Updated: Jan 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome
Masahiko Ochi1, Akinori Hara2,3, Shiori Nakagawa1
1Department of Nephrology and Rheumatology, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.
Background:
The risk factors for the recurrence of idiopathic nephrotic syndrome (INS) remain unknown. Previous studies have suggested a potential link between matrix metalloproteinase-9 (MMP-9) and urinary protein levels in INS. Therefore, we aimed to investigate the association between serum MMP-9 levels and the risk of subsequent recurrence in patients with INS.
Methods:
This retrospective study included 29 patients with biopsy-proven INS from 1998 to 2016. Baseline serum MMP-9 levels during the nephrotic phase were measured using an enzyme-linked immunosorbent assay. Subsequent recurrence was defined as a change in urinary protein levels from remission to more than 2 + on a dipstick test or more than 1 g/g creatinine.
Results:
The median age was 42 years (interquartile range: 26.0, 70.0), and 18 patients were males. Over a median follow-up period of 130 days, 12 patients (41.4%) experienced recurrences. Patients who experienced recurrence were younger and had higher estimated glomerular filtration rates and baseline serum MMP-9 levels during the nephrotic phase than those who did not. Higher baseline serum MMP-9 levels during the nephrotic phase were associated with a higher risk of subsequent recurrence (hazard ratio: 5.687, 95% confidence interval: 1.179-27.44).
Conclusion:
Baseline serum MMP-9 levels during the nephrotic phase were associated with subsequent recurrence in patients with INS, indicating its potential as a predictive marker for future recurrence in patients with INS.
Insights
Higher serum matrix metalloproteinase-9 (MMP-9) levels during nephrotic syndrome predict recurrence risk in patients with idiopathic nephrotic syndrome (INS). This finding suggests MMP-9 may serve as a valuable predictive marker for INS relapse.
Area of Science:
- Nephrology
- Biochemistry
- Clinical Medicine
Background:
- Idiopathic nephrotic syndrome (INS) recurrence risk factors are largely unknown.
- Previous research suggests a link between matrix metalloproteinase-9 (MMP-9) and proteinuria in INS.
- This study investigates serum MMP-9 levels as a predictor of INS recurrence.
Purpose of the Study:
- To determine if baseline serum MMP-9 levels correlate with the risk of subsequent recurrence in patients with INS.
- To explore MMP-9 as a potential biomarker for predicting INS relapse.
Main Methods:
- Retrospective analysis of 29 biopsy-proven INS patients (1998-2016).
- Serum MMP-9 levels measured via ELISA during the nephrotic phase.
- Recurrence defined by urinary protein levels exceeding 2+ or 1 g/g creatinine.
Main Results:
- 12 out of 29 patients (41.4%) experienced recurrence over a median follow-up of 130 days.
- Recurrent patients were younger, had higher eGFR, and higher baseline serum MMP-9 levels.
- Elevated baseline serum MMP-9 significantly increased the risk of subsequent recurrence (HR: 5.687).
Conclusions:
- Baseline serum MMP-9 levels during the nephrotic phase are associated with subsequent INS recurrence.
- Serum MMP-9 shows potential as a predictive marker for future recurrence in INS patients.
More Related Videos
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome I : Introduction
Role of Matrix Metalloproteases in Degradation of ECM
Serum Studies: Renal Function Tests

